Consensus Hepion Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-21 pm EDT			5-day change	1st Jan Change
1.17 ^USD	0.00%		-9.30%	-63.89%

Apr. 22	Sector Update: Health Care Stocks Increase Late Afternoon	MT
Apr. 22	Sector Update: Health Care	MT

d180.QyJ0_LZxnLRYtyXHuPd1zEWZ7WTrnRo1-dMK3Z1hmCA.K24Cv4Vc1PoB3GmIjb9H-jHP2A2o5Gpyq4lmmNYKrHMTEj6y3Ueu_iDPFQ~fc1ec4e5f028604982645e692230df4a

Cantor Fitzgerald Starts Hepion Pharmaceuticals at Overweight With $3.50 Price Target	22-02-28	MT
HEPION PHARMACEUTICALS : Roth Capital Adjusts Price Target on Hepion Pharmaceuticals to $8 From $14, Maintains Buy Rating	20-12-01	MT

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1.17

Average target price

Cantor Fitzgerald